Australian public assessment report for influenza virus ...

Participants aged 19 to 59 years were randomised 1:1:1:1 to four groups of 105 participants. The groups were vaccinated with D-QIV or Fluarix or with a low dose adjuvanted quadrivalent or trivalent vaccine. The quadrivalent vaccine included B/Malaysia/2506/2004 and B/Jiangsu/10/2003. The seasonal vaccine included the B/Malaysia strain. ................
................